---
category: news
title: "BenevolentAI achieves third milestone in its AI-enabled drug discovery collaboration with AstraZeneca"
excerpt: "Second novel target for idiopathic pulmonary fibrosis was discovered using BenevolentAI's drug discovery platform and selected for AstraZeneca's drug development portfolioA total of three targets have"
publishedDateTime: 2022-05-17T05:00:00Z
originalUrl: "https://www.wfmz.com/news/pr_newswire/pr_newswire_stocks/benevolentai-achieves-third-milestone-in-its-ai-enabled-drug-discovery-collaboration-with-astrazeneca/article_a2425252-d8f9-5785-86de-957b0182aa7e.html"
webUrl: "https://www.wfmz.com/news/pr_newswire/pr_newswire_stocks/benevolentai-achieves-third-milestone-in-its-ai-enabled-drug-discovery-collaboration-with-astrazeneca/article_a2425252-d8f9-5785-86de-957b0182aa7e.html"
type: article
quality: 22
heat: -1
published: false

provider:
  name: WFMZ-TV
  domain: wfmz.com

topics:
  - AI

images:
  - url: "https://bloximages.newyork1.vip.townnews.com/wfmz.com/content/tncms/assets/v3/editorial/b/bf/bbfdc644-28a9-56dc-9f73-dd78d7ca195f/61dfee6a70b5c.image.jpg?crop=813%2C427%2C943%2C0&resize=813%2C427&order=crop%2Cresize"
    width: 813
    height: 427
    isCached: true

related:
  - title: "BenevolentAI Says Achieves Third Milestone In AI-enabled Drug Discovery Collaboration With AZN"
    excerpt: "(AZN.L, AZN) has selected an additional novel target for idiopathic pulmonary fibrosis for its drug development portfolio, resulting in a milestone payment to BenevolentAI, the clinical-stage AI-enabled drug discovery company said in a statement."
    publishedDateTime: 2022-05-17T05:16:00Z
    webUrl: "https://www.nasdaq.com/articles/benevolentai-says-achieves-third-milestone-in-ai-enabled-drug-discovery-collaboration-with"
    ampWebUrl: "https://www.nasdaq.com/articles/benevolentai-says-achieves-third-milestone-in-ai-enabled-drug-discovery-collaboration-with?amp"
    cdnAmpWebUrl: "https://www-nasdaq-com.cdn.ampproject.org/c/s/www.nasdaq.com/articles/benevolentai-says-achieves-third-milestone-in-ai-enabled-drug-discovery-collaboration-with?amp"
    type: article
    provider:
      name: Nasdaq
      domain: nasdaq.com
    quality: 55

secured: "4i41QzmsjGWr6rrPdGcBj7OoOWo77OaGeifk5HyiDqjq19CghFFkrGYleLequFYkcvKWj7fwi/nws1XHnp9AMCfAsaBBLUQcy7Wyf+r1qQBlVwIX0N5j2HtpxLKRAra/ZILmT8VvnziIglVfxyzrYvYzkm8GcDjgvdOyeZ5FUv7SpUSBBCfkk1bVOErJjGKuwM/9jRmsF3cCutqDivHoaC00uLMEjHtqJ8fH+N+kEmIOw7f7pjTVkHSQxlGpOvr2vQJAPVAftyWfOPp5AtuMuv1tYIKbrkBKPpRgtgN9h6kYEw0dENiGBCSwhBwndNcH3F3hLEXJHZj3qz3l0GQxn5aNBQSY+js0AOPFuelFUTE=;JuV7t3XuJZ6IRaq90HhT8Q=="
---

